Видео ютуба по тегу Serum And Biocon Biologics

Exclusive | Biocon Biologics Q4: Serum Will Double Investment To $300 Mn
Exclusive | Biocon Biologics Q4: Serum Will Double Investment To $300 Mn
Adar Poonawalla On Serum's $ 300 m Investment In Biocon Biologics | Trading Hour | CNBC-TV18
Adar Poonawalla On Serum's $ 300 m Investment In Biocon Biologics | Trading Hour | CNBC-TV18
Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO
Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO
Biocon Biologics: Revolutionizing Healthcare with Biosimilars
Biocon Biologics: Revolutionizing Healthcare with Biosimilars
#SheInspires: The journey of Winny, Sr. Manager, Research & Development at #BioconBiologics
#SheInspires: The journey of Winny, Sr. Manager, Research & Development at #BioconBiologics
Serum takes its investment in Biocon Bio to $300 Million, Kiran M Shaw On This & More | CNBC-TV18
Serum takes its investment in Biocon Bio to $300 Million, Kiran M Shaw On This & More | CNBC-TV18
'Serum Keen To Have Stake In Biocon Biologics,' Kiran Mazumdar-Shaw On ET Now
'Serum Keen To Have Stake In Biocon Biologics,' Kiran Mazumdar-Shaw On ET Now
Press Meet: Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance (Part 1)
Press Meet: Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance (Part 1)
Biocon Biologics' transformational milestones in 2022.
Biocon Biologics' transformational milestones in 2022.
Biocon Biologics' and Serum Institute Life Sciences' Strategic Alliance
Biocon Biologics' and Serum Institute Life Sciences' Strategic Alliance
SheAspires: Young Women Shaping the Future of Healthcare at Biocon Biologics
SheAspires: Young Women Shaping the Future of Healthcare at Biocon Biologics
Biocon Biologics: Shifting the access paradigm by providing affordable quality insulins worldwide.
Biocon Biologics: Shifting the access paradigm by providing affordable quality insulins worldwide.
Highlights Of #Q3FY21
Highlights Of #Q3FY21
Our acquisition of Viatris business has been 'spooking the Indian investor,' biotechnology firm says
Our acquisition of Viatris business has been 'spooking the Indian investor,' biotechnology firm says
#SheInspires: The journey of Kavya from an Intern to Associate Scientific Manager, #BioconBiologics
#SheInspires: The journey of Kavya from an Intern to Associate Scientific Manager, #BioconBiologics
Biocon Conference Call: Biocon Biologics and Serum Institute Merger Announcement
Biocon Conference Call: Biocon Biologics and Serum Institute Merger Announcement
Strong Biosimilar Growth Powers Biocon | Trading Hour | CNBC TV18
Strong Biosimilar Growth Powers Biocon | Trading Hour | CNBC TV18
Press Meet: Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance (Part 2)
Press Meet: Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance (Part 2)
Spotlight On Biocon-Serum Deal, Ipca's Unichem Acquisitions & Mankind Pharma's IPO | CNBC-TV18
Spotlight On Biocon-Serum Deal, Ipca's Unichem Acquisitions & Mankind Pharma's IPO | CNBC-TV18